Evidence map›Paper›PMID 28741096›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.

R Falcón, E M Mateo, A Talaya, E Giménez, V Vinuesa, M Á Clari, D Navarro

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

R FalcónMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
E M MateoMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
A TalayaMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
E GiménezMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
V VinuesaMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
M Á ClariMicrobiology Unit, Hospital San Francisco de Borja, Gandía, Spain.
D NavarroMicrobiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain. david.navarro@uv.es.ORCID http://orcid.org/0000-0003-3010-4110
INCLIVA Health Research Institute · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The availability of reproducible broth microdilution (BMD) methods including inter log

Indexed as

Anti-Bacterial AgentsDose-Response Relationship, DrugMicrobial Sensitivity TestsReproducibility of ResultsStaphylococcus aureusVancomycinAnti-Bacterial AgentsVancomycin

Identifiers

PMID28741096
OpenAlexW2738160971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.